クロシンの市場規模、シェア、動向分析レポート：用途別（食品、医薬品）、純度別（純度98%超、純度98%未満）、適応症別（疼痛）、流通チャネル別（病院薬局）、地域別、セグメント別予測、2023～2030年

クロシン市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界のクロシン市場規模は、2023年から2030年にかけて5.14%のCAGRで拡大し、2030年には67億9,000万米ドルに達すると予想されています。

クロシン市場の成長は、心血管障害やがんなどの慢性疾患の有病率の世界の上昇と急速な高齢化に起因しています。全米慢性疾患担当者協会が発表した「2022年の慢性疾患予防に関する解説」によると、成人アメリカ人の60%近くが少なくとも1つの慢性疾患を抱えています。

WHOによると、口腔疾患は約35億5,000万人に影響を与え、不快感や痛みを引き起こしています。パラセタモールは、頭痛、歯痛、腰痛、発熱、神経性の不快感、変形性関節症など、軽度から中等度の痛みの治療によく使われます。痛みのレベルが上がるにつれて、鎮痛剤の必要性も高まっています。

痛みの発生率の上昇は、予測期間中、NSAIDsの市場成長を後押しすると予想されます。2019年のCDCによると、米国では成人人口の約20.4%が慢性疼痛に苦しんでいます。例えば、WHOが発表した統計によると、世界では6人に1人が60歳以上となり、2050年には60歳以上の人口が2倍、つまり21億人になると言われています。

パラセタモールは、高齢者の疼痛管理、あるいは腰痛や筋骨格系疾患の治療に最もよく使われる鎮痛剤です。インフルエンザの流行が高まり、OTC製品の使用が増加していることが、成長を後押ししています。片頭痛は、頭痛やその他の合併症を引き起こす最も一般的な疾患のひとつで、クロシンやパラセタモールの使用率が非常に高くなっています。

さらに、主要企業は、製品ポートフォリオと製造能力を強化し、競争上の差別化を図るために、合併、買収＆パートナーシップ、製品発表に取り組んでいます。例えば、2022年8月、Haleon Group of Companiesは、イブプロフェンとアセトアミノフェンを含む1錠の「New Advil PLUS Acetaminophen」をカナダで発売しました。

クロシン市場レポートハイライト

• 痛みや発熱を和らげるために使用されるパラセタモールの生産が増加していることから、医薬品分野が市場を独占しています。さらに、痛みに関連する疾患の治療において、さまざまな製剤に含まれるパラセタモールの使用が増加しており、市場の成長をさらに促進すると予想されます。
• 2022年のクロシン市場シェアは、純度>98%セグメントが過半数を占めました。しかし、純度98%未満セグメントは予測期間中に大きな成長を示すと予想されます。
• 痛みセグメントは、市場で入手可能な他の鎮痛剤と比較して副作用が少ない店頭（OTC）鎮痛剤としてのパラセタモールの使用量が増加しているため、市場を独占しています。
• 2022年のクロシン市場は、病院薬局セグメントが支配的でした。しかし、OTC製品の採用が増加していることから、小売薬局セグメントは予測期間中に大きな成長を遂げると予想されます。
• 2022年の市場では、北米が最大のシェアを占めています。同地域の成長は、同地域の人口の間で疼痛管理薬に対するニーズが高まっていることに起因すると考えられます。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース：
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査の詳細
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
    • アプローチ：コモディティフローアプローチ
• 調査の仮定
• 二次情報のリスト
• 略語のリスト
• 目的

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 クロシン市場の変数、動向、および範囲

• クロシン市場系統の見通し
  • 親市場の見通し
  • 補助的な市場展望- 非ステロイド性抗炎症薬市場
• バリューチェーン分析
  • 原材料の見通し
  • 製品メーカー
  • サプライヤー
  • 利用者
• 数量動向分析（2018-2030）
• 価格動向分析
  • 調剤された剤形の配布
• 規制の枠組み
• 市場力学
  • 市場促進要因の影響分析
    • 頭痛、インフルエンザ、その他の痛みに関連する症状の有病率の上昇
    • 疼痛管理薬の需要の増加
    • パラセタモールの生産量の増加
  • 市場抑制要因分析
    • パラセタモールの過剰摂取別副作用
    • 市場での代替鎮痛剤の入手可能性
• 業界分析ツール
  • ポーターの分析
  • マクロ経済分析

第4章 クロシン市場- 用途別セグメント分析、2018年～2030年

• クロシン市場：用途の変動分析
• 用途別
  • 食品
  • 化学工業
  • 医薬品
  • その他

第5章 クロシン市場- セグメント分析、純度別、2018-2030

• クロシン市場：純度変動分析
• 純度別
  • 純度 98%超
  • 純度 98%未満

第6章 クロシン市場- 適応症別セグメント分析、2018年～2030年

• クロシン市場：指標変動分析
• 適応症別
  • 疼痛
  • 発熱

第7章 クロシン市場- セグメント分析、流通チャネル別、2018-2030

• クロシン市場：流通チャネルの変動分析
• 流通チャネル別
  • 病院薬局
  • 小売薬局
  • その他

第8章 クロシン市場：用途別、純度別、適応症別、流通チャネル別の地域推定・動向分析

• クロシン市場：地域別展望
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
• 中東とアフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第9章 クロシン市場- 競合分析

• 主要市場参入企業別最近の動向と影響分析
  • アンソフマトリックス
  • ヒートマップ分析
  • 主な取引と戦略アライアンス分析
    • 合弁事業
    • ライセンシング契約
    • 製品の発売
    • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • マーケットリーダー
• ベンダー情勢
  • 主なディストリビューターとチャネルパートナーのリスト
  • 主な顧客
• 公開会社
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要な新興企業のリスト
• 企業プロファイル
  • TCI Chemicals Pvt. Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Merck KGaA
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • GSK plc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Cayman Chemical
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • APExBIO Technology
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Wilshire Technologies
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Biosynth
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Cipla, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Novartis AG
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Sanofi
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Aurobindo Pharma
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Teva Pharmaceutical Industries Ltd.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み
  • Mallinckrodt
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的取り組み

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global crocin market, by purity, 2018 - 2030 (USD Million)
• Table 4 Global crocin market, by indication, 2018 - 2030 (USD Million)
• Table 5 Global crocin market, by application, 2018 - 2030 (USD Million)
• Table 6 Global crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 7 Global crocin market, by region, 2018 - 2030 (USD Million)
• Table 8 North America crocin market, by country, 2018 - 2030 (USD Million)
• Table 9 North America crocin market, by purity,2018 - 2030 (USD Million)
• Table 10 North America crocin market, by indication, 2018 - 2030 (USD Million)
• Table 11 North America crocin market, by application, 2018 - 2030 (USD Million)
• Table 12 North America crocin market, by distribution channel, 2018 - 20
• Table 13 U.S. crocin market, by purity,2018 - 2030 (USD Million)
• Table 14 U.S. crocin market, by indication, 2018 - 2030 (USD Million)
• Table 15 U.S. crocin market, by application, 2018 - 2030 (USD Million)
• Table 16 U.S. crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 17 Canada crocin market, by purity,2018 - 2030 (USD Million)
• Table 18 Canada crocin market, by indication, 2018 - 2030 (USD Million)
• Table 19 Canada crocin market, by application, 2018 - 2030 (USD Million)
• Table 20 Canada crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 21 Europe crocin market, by country, 2018 - 2030 (USD Million)
• Table 22 Europe crocin market, by purity,2018 - 2030 (USD Million)
• Table 23 Europe crocin market, by indication, 2018 - 2030 (USD Million)
• Table 24 Europe crocin market, by application, 2018 - 2030 (USD Million)
• Table 25 Europe crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 26 UK crocin market, by purity,2018 - 2030 (USD Million)
• Table 27 UK crocin market, by indication, 2018 - 2030 (USD Million)
• Table 28 UK crocin market, by application, 2018 - 2030 (USD Million)
• Table 29 UK crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 30 Germany crocin market, by purity,2018 - 2030 (USD Million)
• Table 31 Germany crocin market, by indication, 2018 - 2030 (USD Million)
• Table 32 Germany crocin market, by application, 2018 - 2030 (USD Million)
• Table 33 Germany crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 34 France crocin market, by purity,2018 - 2030 (USD Million)
• Table 35 France crocin market, by indication, 2018 - 2030 (USD Million)
• Table 36 France crocin market, by application, 2018 - 2030 (USD Million)
• Table 37 France crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 38 Italy crocin market, by purity,2018 - 2030 (USD Million)
• Table 39 Italy crocin market, by indication, 2018 - 2030 (USD Million)
• Table 40 Italy crocin market, by application, 2018 - 2030 (USD Million)
• Table 41 Italy crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42 Spain crocin market, by purity,2018 - 2030 (USD Million)
• Table 43 Spain crocin market, by indication, 2018 - 2030 (USD Million)
• Table 44 Spain crocin market, by application, 2018 - 2030 (USD Million)
• Table 45 Spain crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46 Sweden crocin market, by purity,2018 - 2030 (USD Million)
• Table 47 Sweden crocin market, by indication, 2018 - 2030 (USD Million)
• Table 48 Sweden crocin market, by application, 2018 - 2030 (USD Million)
• Table 49 Sweden crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 Denmark crocin market, by purity, 2018 - 2030 (USD Million)
• Table 51 Denmark crocin market, by indication, 2018 - 2030 (USD Million)
• Table 52 Denmark crocin market, by application, 2018 - 2030 (USD Million)
• Table 53 Denmark crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 54 Norway crocin market, by purity, 2018 - 2030 (USD Million)
• Table 55 Norway crocin market, by indication, 2018 - 2030 (USD Million)
• Table 56 Norway crocin market, by application, 2018 - 2030 (USD Million)
• Table 57 Norway crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific crocin market, by country, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific crocin market, by purity, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific crocin market, by indication, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific crocin market, by application, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 63 Japan crocin market, by purity, 2018 - 2030 (USD Million)
• Table 64 Japan crocin market, by indication, 2018 - 2030 (USD Million)
• Table 65 Japan crocin market, by application, 2018 - 2030 (USD Million)
• Table 66 Japan crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 67 India crocin market, by purity, 2018 - 2030 (USD Million)
• Table 68 India crocin market, by indication, 2018 - 2030 (USD Million)
• Table 69 India crocin market, by application, 2018 - 2030 (USD Million)
• Table 70 India crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 71 China crocin market, by purity, 2018 - 2030 (USD Million)
• Table 72 China crocin market, by indication, 2018 - 2030 (USD Million)
• Table 73 China crocin market, by application, 2018 - 2030 (USD Million)
• Table 74 China crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 75 Australia crocin market, by purity, 2018 - 2030 (USD Million)
• Table 76 Australia crocin market, by indication, 2018 - 2030 (USD Million)
• Table 77 Australia crocin market, by application, 2018 - 2030 (USD Million)
• Table 78 Australia crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 79 South Korea crocin market, by purity, 2018 - 2030 (USD Million)
• Table 80 South Korea crocin market, by indication, 2018 - 2030 (USD Million)
• Table 81 South Korea crocin market, by application, 2018 - 2030 (USD Million)
• Table 82 South Korea crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 83 Thailand crocin market, by purity, 2018 - 2030 (USD Million)
• Table 84 Thailand crocin market, by indication, 2018 - 2030 (USD Million)
• Table 85 Thailand crocin market, by application, 2018 - 2030 (USD Million)
• Table 86 Thailand crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 87 Latin America crocin market, by country, 2018 - 2030 (USD Million)
• Table 88 Latin America crocin market, by purity,2018 - 2030 (USD Million)
• Table 89 Latin America crocin market, by indication, 2018 - 2030 (USD Million)
• Table 90 Latin America crocin market, by application, 2018 - 2030 (USD Million)
• Table 91 Latin America crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 92 Brazil crocin market, by product types, 2018 - 2030 (USD Million)
• Table 93 Brazil crocin market, by indication, 2018 - 2030 (USD Million)
• Table 94 Brazil crocin market, by application, 2018 - 2030 (USD Million)
• Table 95 Brazil crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 96 Mexico crocin market, by purity, 2018 - 2030 (USD Million)
• Table 97 Mexico crocin market, by indication, 2018 - 2030 (USD Million)
• Table 98 Mexico crocin market, by application, 2018 - 2030 (USD Million)
• Table 99 Mexico crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 100 Argentina crocin market, by purity, 2018 - 2030 (USD Million)
• Table 101 Argentina crocin market, by indication, 2018 - 2030 (USD Million)
• Table 102 Argentina crocin market, by application, 2018 - 2030 (USD Million)
• Table 103 Argentina crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa crocin market, by country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa crocin market, by purity, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa crocin market, by indication, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa crocin market, by application, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 109 South Africa crocin market, by purity, 2018 - 2030 (USD Million)
• Table 110 South Africa crocin market, by indication, 2018 - 2030 (USD Million)
• Table 111 South Africa crocin market, by application, 2018 - 2030 (USD Million)
• Table 112 South Africa crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia crocin market, by purity, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia crocin market, by indication, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia crocin market, by application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 117 UAE crocin market, by purity, 2018 - 2030 (USD Million)
• Table 118 UAE crocin market, by indication, 2018 - 2030 (USD Million)
• Table 119 UAE crocin market, by application, 2018 - 2030 (USD Million)
• Table 120 UAE crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 121 Kuwait crocin market, by purity, 2018 - 2030 (USD Million)
• Table 122 Kuwait crocin market, by indication, 2018 - 2030 (USD Million)
• Table 123 Kuwait crocin market, by application, 2018 - 2030 (USD Million)
• Table 124 Kuwait crocin market, by distribution channel, 2018 - 2030 (USD Million)
• Table 125 Participant's overview
• Table 126 Financial performance
• Table 127 Key Companies undergoing Expansions.
• Table 128 Key Companies undertaking Acquisitions.
• Table 129 Key Companies undergoing Collaborations.
• Table 130 Key Companies Launching New Products/Services
• Table 131 Key Companies undergoing Partnerships.
• Table 132 Key Companies undergoing Other Strategies 

List of Figures

• Fig. 1 Crocin market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value - chain - based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Crocin market driver analysis
• Fig. 13 Crocin market restraint analysis
• Fig. 14 Crocin market: Porter's analysis
• Fig. 15 Crocin market: PESTLE analysis
• Fig. 16 Crocin market: Purity outlook and key takeaways
• Fig. 17 Crocin market: Purity market share analysis, 2022 - 2030
• Fig. 18 Global purity>98% market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 19 Global purity<98% market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Crocin market: Application outlook and key takeaways
• Fig. 22 Crocin market: Application market share analysis, 2022 - 2030
• Fig. 23 Global food market, 2018 - 2030 (USD Million)
• Fig. 24 Global chemical market, 2018 - 2030 (USD Million)
• Fig. 25 Global drug market, 2018 - 2030 (USD Million)
• Fig. 26 Global others market, 2018 - 2030 (USD Million)
• Fig. 27 Crocin market: Indication outlook and key takeaways
• Fig. 28 Crocin market: Indication market share analysis, 2022 - 2030
• Fig. 29 Global pain market, 2018 - 2030 (USD Million)
• Fig. 30 Global pyrexia market, 2018 - 2030 (USD Million)
• Fig. 31 Crocin market: Distribution channel outlook and key takeaways
• Fig. 32 Crocin market: Distribution channel market share analysis, 2022 - 2030
• Fig. 33 Global hospital pharmacies market, 2018 - 2030 (USD Million)
• Fig. 34 Global retail pharmacies market, 2018 - 2030 (USD Million)
• Fig. 35 Global others market, 2018 - 2030 (USD Million)
• Fig. 36 North America: SWOT Analysis
• Fig. 37 Europe: SWOT Analysis
• Fig. 38 Asia Pacific : SWOT Analysis
• Fig. 39 Latin America: SWOT Analysis
• Fig. 40 MEA: SWOT Analysis
• Fig. 41 North America crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 U.S. crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 U.S.: Country dynamics
• Fig. 44 Canada crocin market, 2018 - 2030 (USD Million)
• Fig. 45 Canada: Country dynamics
• Fig. 46 Europe crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 UK crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 UK: Country dynamics
• Fig. 49 Germany crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Germany: Country dynamics
• Fig. 51 France crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 France: Country dynamics
• Fig. 53 Italy crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Italy: Country dynamics
• Fig. 55 Spain crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Spain: Country dynamics
• Fig. 57 Denmark crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Denmark: Country dynamics
• Fig. 59 Sweden crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Sweden: Country dynamics
• Fig. 61 Norway crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Norway: Country dynamics
• Fig. 63 Asia - Pacific crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Japan crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Japan: Country dynamics
• Fig. 66 China crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 China: Country dynamics
• Fig. 68 India crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 India: Country dynamics
• Fig. 70 Australia crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Australia: Country dynamics
• Fig. 72 Thailand crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Thailand: Country dynamics
• Fig. 74 South Korea crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 South Korea: Country dynamics
• Fig. 76 Latin America crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Brazil crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Brazil: Country dynamics
• Fig. 79 Mexico crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Mexico: Country dynamics
• Fig. 81 Argentina crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 82 Argentina: Country dynamics
• Fig. 83 MEA crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 South Africa crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 South Africa: Country dynamics
• Fig. 86 Saudi Arabia crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Saudi Arabia: Country dynamics
• Fig. 88 UAE crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 UAE: Country dynamics
• Fig. 90 Kuwait crocin market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 91 Kuwait: Country dynamics
• Fig. 92 Key company categorization
• Fig. 93 Company market share analysis
• Fig. 94 Company market position analysis
• Fig. 95 Market participant categorization
• Fig. 96 Strategy framework

Crocin Market Growth & Trends:

The global crocin market size is expected to reach USD 6.79 billion by 2030, expandingat a CAGR of 5.14% from 2023 to 2030, according to a new report by Grand View Research, Inc. The crocin market growth is attributed to the global rise in the prevalence of chronic diseases such as cardiovascular disorders & cancer and the rapidly aging population. According to the Commentary on Chronic Disease Prevention in 2022 published by the National Association of Chronic Disease Directors, nearly 60% of adult Americans have at least one chronic disease.

Oral diseases affect approximately 3.55 bn people, causing discomfort and pain, according to WHO. Paracetamol is commonly used to treat minor to moderate pain, such as headaches, toothaches, backaches, fever, neurological discomfort, and osteoarthritis. As pain levels rise, so does the need for relievers.

The rising incidence of pain is expected to boost the market growth of NSAIDs during the forecast period. According to the CDC in 2019, around 20.4% of the adult population suffered from chronic pain in the U.S. For instance, 1 in 6 people will be over the age of 60 years in the world and by 2050 the population of people aged 60 years and above would double i.e., 2.1 billion, as per the statistics published by WHO.

Paracetamol is the most commonly used analgesic in older people as a means of pain management or mostly to treat lower back or musculoskeletal-related conditions. The rising prevalence of flu and the increased use of OTC products are propelling growth. Migraine is one of the most common diseases, causing headaches and other complications where the usage of Crocin or paracetamol is very high.

Furthermore, key players are engaged in mergers, acquisitions & partnerships, and product launches to strengthen their product portfolios & manufacturing capacities and provide competitive differentiation. For instance, in August 2022, Haleon Group of Companies introduced New Advil PLUS Acetaminophen, a single tablet containing ibuprofen and acetaminophen, in Canada.

Crocin Market Report Highlights:

• Drugs segment dominated the market attributing to the increasing production of paracetamol to be used for relieving pain and fever. Moreover, the increasing use of paracetamol in various formulations in the treatment of pain-related conditions is expected to further propel the growth

• Purity >98% segment held the majority of the crocin market share in 2022. However, the purity <98% segment is expected to show significant growth over the forecast period

• Pain segment dominated the market owing to the increasing usage of paracetamol as an Over-The-Counter (OTC) analgesic with lesser side effects as compared to other painkillers available in the market

• Hospital pharmacy segment dominated the crocin market in 2022. However, the retail pharmacy segment is expected to grow at a significant rate over the forecast period owing to the increasing adoption of OTC products

• North America held the largest share of the market in 2022. The growth in the region can be attributed to the increasing need for pain management drugs among the population in the region

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 Crocin Market Variables, Trends, & Scope

• 3.1 Crocin Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook - Non-Steroidal Anti-Inflammatory Drugs Market
• 3.2 Value Chain Analysis
  • 3.2.1 Raw Material Outlook
  • 3.2.2 Product Manufacturers
  • 3.2.3 Suppliers
  • 3.2.4 End-Users
• 3.3 Volume Trend Analysis (2018-2030)
• 3.4 Price Trend Analysis
  • 3.4.1 Distribution Of Dispensed Dosage Forms
• 3.5 Regulatory Framework
• 3.6 Market Dynamics
  • 3.6.1 Market Driver Impact Analysis
    • 3.6.1.1 Rising Prevalence Of Headaches, Flu, And Other Pain-Related Conditions
    • 3.6.1.2 Increasing Demand For Pain Management Drugs
    • 3.6.1.3 Increased Production Of Paracetamol
  • 3.6.2 Market Restraint Analysis
    • 3.6.2.1 Side Effects Of Overdosage Of Paracetamol
    • 3.6.2.2 Availability Of Alternative Painkillers In The Market
• 3.7 Industry Analysis Tools
  • 3.7.1 Porter's Analysis
  • 3.7.2 Macroeconomic Analysis

Chapter 4 Crocin Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 4.1 Crocin Market: Application Movement Analysis
• 4.2 Crocin Market Estimates & Forecast, By Application (USD Million)
  • 4.2.1 Food
  • 4.2.2 Chemical Industry
  • 4.2.3 Drug
  • 4.2.4 Others

Chapter 5 Crocin Market - Segment Analysis, By Purity, 2018 - 2030 (USD Million)

• 5.1 Crocin Market: Purity Movement Analysis
• 5.2 Crocin Market Estimates & Forecast, By Purity (USD Million)
  • 5.2.1 Purity >98%
  • 5.2.2 Purity <98%

Chapter 6 Crocin Market - Segment Analysis, by Indication, 2018 - 2030 (USD Million)

• 6.1 Crocin Market: Indication Movement Analysis
• 6.2 Crocin Market Estimates & Forecast, by Indication (USD Million)
  • 6.2.1 Pain
  • 6.2.2 Pyrexia (Fever)

Chapter 7 Crocin Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

• 7.1 Crocin Market: Distribution Channel Movement Analysis
• 7.2 Crocin Market Estimates & Forecast, By Distribution Channel (USD Million)
  • 7.2.1 Hospital Pharmacy
  • 7.2.2 Retail Pharmacy
  • 7.2.3 Others

Chapter 8 Crocin Market: Regional Estimates And Trend Analysis, By Application, By Purity, By Indication, And By Distribution Channel

• 8.1 Crocin Market: Regional Outlook
• 8.2 North America
  • 8.2.1 North America Crocin Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key Country Dynamics
    • 8.2.2.2 U.S. Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.2.2.3 Target Disease Incidence
    • 8.2.2.4 Target Disease Prevalence
    • 8.2.2.5 Competitive Scenario
    • 8.2.2.6 Regulatory Framework
    • 8.2.2.7 Reimbursement Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Canada Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.2.3.3 Target Disease Incidence
    • 8.2.3.4 Competitive Scenario
    • 8.2.3.5 Regulatory Framework
    • 8.2.3.6 Reimbursement Scenario
• 8.3 Europe
  • 8.3.1 Europe Crocin Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 Germany
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 Germany Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.2.3 Target Disease Incidence
    • 8.3.2.4 Competitive Scenario
    • 8.3.2.5 Regulatory Framework
    • 8.3.2.6 Reimbursement Scenario
  • 8.3.3 Uk
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Uk Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.3.3 Target Disease Incidence
    • 8.3.3.4 Competitive Scenario
    • 8.3.3.5 Regulatory Framework
    • 8.3.3.6 Reimbursement Scenario
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 France Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.4.3 Target Disease Incidence
    • 8.3.4.4 Competitive Scenario
    • 8.3.4.5 Regulatory Framework
    • 8.3.4.6 Reimbursement Scenario
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Italy Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.5.3 Target Disease Incidence
    • 8.3.5.4 Competitive Scenario
    • 8.3.5.5 Regulatory Framework
    • 8.3.5.6 Reimbursement Scenario
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Spain Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.6.3 Target Disease Incidence
    • 8.3.6.4 Competitive Scenario
    • 8.3.6.5 Regulatory Framework
    • 8.3.6.6 Reimbursement Scenario
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Denmark Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.7.3 Target Disease Incidence
    • 8.3.7.4 Competitive Scenario
    • 8.3.7.5 Regulatory Framework
    • 8.3.7.6 Reimbursement Scenario
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Sweden Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.8.3 Target Disease Incidence
    • 8.3.8.4 Competitive Scenario
    • 8.3.8.5 Regulatory Framework
    • 8.3.8.6 Reimbursement Scenario
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Norway Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.3.9.3 Target Disease Incidence
    • 8.3.9.4 Competitive Scenario
    • 8.3.9.5 Regulatory Framework
    • 8.3.9.6 Reimbursement Scenario
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific Crocin Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 China
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 China Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.2.3 Target Disease Incidence
    • 8.4.2.4 Competitive Scenario
    • 8.4.2.5 Regulatory Framework
    • 8.4.2.6 Reimbursement Scenario
  • 8.4.3 India
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 India Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.3.3 Target Disease Incidence
    • 8.4.3.4 Competitive Scenario
    • 8.4.3.5 Regulatory Framework
    • 8.4.3.6 Reimbursement Scenario
  • 8.4.4 Japan
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 Japan Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.4.3 Target Disease Incidence
    • 8.4.4.4 Competitive Scenario
    • 8.4.4.5 Regulatory Framework
    • 8.4.4.6 Reimbursement Scenario
  • 8.4.5 South Korea
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 South Korea Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.5.3 Target Disease Incidence
    • 8.4.5.4 Competitive Scenario
    • 8.4.5.5 Regulatory Framework
    • 8.4.5.6 Reimbursement Scenario
  • 8.4.6 Australia
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Australia Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.6.3 Target Disease Incidence
    • 8.4.6.4 Competitive Scenario
    • 8.4.6.5 Regulatory Framework
    • 8.4.6.6 Reimbursement Scenario
  • 8.4.7 Thailand
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 Thailand Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.4.7.3 Target Disease Incidence
    • 8.4.7.4 Competitive Scenario
    • 8.4.7.5 Regulatory Framework
    • 8.4.7.6 Reimbursement Scenario
• 8.5 Latin America
  • 8.5.1 Latin America Crocin Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2 Argentina
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Argentina Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.5.2.3 Target Disease Incidence
    • 8.5.2.4 Competitive Scenario
    • 8.5.2.5 Regulatory Framework
    • 8.5.2.6 Reimbursement Scenario
  • 8.5.3 Brazil
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Brazil Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.5.3.3 Target Disease Incidence
    • 8.5.3.4 Competitive Scenario
    • 8.5.3.5 Regulatory Framework
    • 8.5.3.6 Reimbursement Scenario
  • 8.5.4 Mexico
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Mexico Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.5.4.3 Target Disease Incidence
    • 8.5.4.4 Competitive Scenario
    • 8.5.4.5 Regulatory Framework
    • 8.5.4.6 Reimbursement Scenario
• 8.6 Middle East and Africa
  • 8.6.1 Middle East And Africa Crocin Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.1.1 Target Disease Incidence
    • 8.6.1.2 Competitive Scenario
    • 8.6.1.3 Regulatory Framework
    • 8.6.1.4 Reimbursement Scenario
  • 8.6.2 Saudi Arabia
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Saudi Arabia Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.6.2.3 Target Disease Incidence
    • 8.6.2.4 Competitive Scenario
    • 8.6.2.5 Regulatory Framework
    • 8.6.2.6 Reimbursement Scenario
  • 8.6.3 South Africa
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 South Africa Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.6.3.3 Target Disease Incidence
    • 8.6.3.4 Competitive Scenario
    • 8.6.3.5 Regulatory Framework
    • 8.6.3.6 Reimbursement Scenario
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 UAE Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.6.4.3 Target Disease Incidence
    • 8.6.4.4 Competitive Scenario
    • 8.6.4.5 Regulatory Framework
    • 8.6.4.6 REIMBURSEMENT SCENARIO
  • 8.6.5 KUWAIT
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Kuwait Crocin Market Estimates & Forecasts And Trend Analysis, 2018 - 2030 (USD Million)
    • 8.6.5.3 Target Disease Incidence
    • 8.6.5.4 Competitive Scenario
    • 8.6.5.5 Regulatory Framework
    • 8.6.5.6 Reimbursement Scenario

Chapter 9 Crocin Market - Competitive Analysis

• 9.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 9.1.1 Ansoff Matrix
  • 9.1.2 Heat Map Analysis
  • 9.1.3 Major Deals and Strategic Alliances Analysis
    • 9.1.3.1 Joint Ventures
    • 9.1.3.2 Licensing Agreements
    • 9.1.3.3 Product Launches
    • 9.1.3.1 Conferences and Campaigns
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
• 9.3 Vendor Landscape
  • 9.3.1 List of key distributors and channel partners
  • 9.3.2 Key customers
• 9.4 Public Companies
  • 9.4.1 Competitive Dashboard Analysis
    • 9.4.1.1 Market Differentiators
• 9.5 Private Companies
  • 9.5.1 List of key emerging companies
• 9.6 Company Profiles
  • 9.6.1 TCI Chemicals Pvt. Ltd.
    • 9.6.1.1 Company overview
    • 9.6.1.2 Financial performance
    • 9.6.1.3 Product benchmarking
    • 9.6.1.4 Strategic Initiatives
  • 9.6.2 Merck KGaA
    • 9.6.2.1 Company overview
    • 9.6.2.2 Financial performance
    • 9.6.2.3 Product benchmarking
    • 9.6.2.4 Strategic Initiatives
  • 9.6.3 GSK plc.
    • 9.6.3.1 Company overview
    • 9.6.3.2 Financial performance
    • 9.6.3.3 Product benchmarking
    • 9.6.3.4 Strategic Initiatives
  • 9.6.4 Cayman Chemical
    • 9.6.4.1 Company overview
    • 9.6.4.2 Financial performance
    • 9.6.4.3 Product benchmarking
    • 9.6.4.4 Strategic Initiatives
  • 9.6.5 APExBIO Technology
    • 9.6.5.1 Company overview
    • 9.6.5.2 Financial performance
    • 9.6.5.3 Product benchmarking
    • 9.6.5.4 Strategic Initiatives
  • 9.6.6 Wilshire Technologies
    • 9.6.6.1 Company overview
    • 9.6.6.2 Financial performance
    • 9.6.6.3 Product benchmarking
    • 9.6.6.4 Strategic Initiatives
  • 9.6.7 Biosynth
    • 9.6.7.1 Company overview
    • 9.6.7.2 Financial performance
    • 9.6.7.3 Product benchmarking
    • 9.6.7.4 Strategic initiatives
  • 9.6.8 Cipla, Inc.
    • 9.6.8.1 Company overview
    • 9.6.8.2 Financial performance
    • 9.6.8.3 Product benchmarking
    • 9.6.8.4 Strategic initiatives
  • 9.6.9 Novartis AG
    • 9.6.9.1 Company overview
    • 9.6.9.2 Financial performance
    • 9.6.9.3 Product benchmarking
    • 9.6.9.4 Strategic initiatives
  • 9.6.10 Sanofi
    • 9.6.10.1 Company overview
    • 9.6.10.2 Financial performance
    • 9.6.10.3 Product benchmarking
    • 9.6.10.4 Strategic initiatives
  • 9.6.11 Aurobindo Pharma
    • 9.6.11.1 Company overview
    • 9.6.11.2 Financial performance
    • 9.6.11.3 Product benchmarking
    • 9.6.11.4 Strategic initiatives
  • 9.6.12 Teva Pharmaceutical Industries Ltd.
    • 9.6.12.1 Company overview
    • 9.6.12.2 Financial performance
    • 9.6.12.3 Product benchmarking
    • 9.6.12.4 Strategic initiatives
  • 9.6.13 Mallinckrodt
    • 9.6.13.1 Company overview
    • 9.6.13.2 Financial performance
    • 9.6.13.3 Product benchmarking
    • 9.6.13.4 Strategic initiatives